NCT02289898 2020-09-28
YOSEMITE
Mereo BioPharma
Phase 2 Completed
Clinical Trials
7 trialsNCT00744562 2020-09-10
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Mereo BioPharma
Phase 1 Completed
NCT01189929 2020-09-09
A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer
Mereo BioPharma
Phase 1 Completed
NCT01189942 2020-09-09
A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer
Mereo BioPharma
Phase 1 Completed
NCT01189968 2020-09-09
A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer
Mereo BioPharma
Phase 1 Completed
NCT02259582 2020-09-09
DENALI
Mereo BioPharma
Phase 2 Completed
NCT02722954 2020-08-11
A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors
Mereo BioPharma
Phase 1 Completed